“Viagra for women” will soon appear in the USA

A commission of experts in the United States applied to the regulatory authority of the Food and Drug Administration (FDA) with a proposal to approve the drug fibanserin, which is prescribed to women in order to increase sexual attraction.

Experts found it possible to recommend a drug with a patented name flibanserin, which many perceive as “Viagra for women.”

However, experts insist that fibanserin should be distributed with a warning about possible side effects, including fainting and fatigue.

The FDA with 2010 has already refused to certify the drug twice, but usually it follows the recommendations of its experts.

During clinical trials, patients reported a slight, albeit small, increase in the number of sexual acts that brought them satisfaction.

“But on the other hand, even modest results can be important in a particular clinical situation,” said Dr. Julia Hyman of the Kinsey Institute at Indiana University.

Subjective factor

Amanda Parrish, who took the drug, explained its appeal: “It's very simple - I want to desire my husband. For us, flibanserin was the medicine that saved our married life.”

The drug was developed by Sprout Pharmaceuticals. The company's lobbyists came to the aid of the feminist organization Even the Score, which accused the FDA of discrimination against women: American regulators approved a number of drugs for the treatment of erectile dysfunction in men, but not a single similar drug for women.

However, the low efficacy of the drug still confuses many.

“The approval of this drug would set the worst possible precedent—that companies that spend enough money could lobby for the approval of useless or dangerous drugs,” the New York Times quoted Dr. Adrian Few-Berman of Georgetown University as saying.

If approved, fibanserin will be given to women in pre-menopausal age.